Gerresheimer stock slips 0.42% to EUR 30.93 premarket
Published on 11/17/2026 at 07:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- Gerresheimer serves pharmaceutical, biopharmaceutical and veterinary applications.
- The investor calendar lists a Q3 quarterly update for December 2026.
- The stock points lower in premarket trading before the next session.
Premarket quote points lower
Gerresheimer stock traded at 30.93 euros on Lang & Schwarz at 07:55 CET on Tuesday, November 17, 2026, 0.42 percent below the Xetra close of 31.06 euros on Monday, November 16.
Gerresheimer's investor relations page places the company in pharmaceutical, biopharmaceutical and veterinary applications. The investor calendar lists a Q3 quarterly update for December 2026.
German equities will be watched alongside the current market reports.
Disclaimer...
en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70525153 | bgmi
